AstraZeneca resumes COVID-19 vaccine trial after UK green light

AstraZeneca announced on Wednesday it had “voluntarily paused” its trial of the vaccine developed alongside Oxford University after the volunteer developed an unexplained illness.


Read the full story: Read More